Maureen T. Cronin
Geen lopende functies
Profiel
Maureen T.
Cronin worked as an Executive Director-Research Informatics at Celgene Corp.
from 2012 to 2017.
She was also a Senior Director-Applied Genomics at ACLARA Biosciences, Inc. and a Program Lead at Affymetrix, Inc. She served as an Independent Director at Celcuity, Inc. from 2017 to 2019.
From 2018 to 2020, she was the Chief Scientific Officer & Senior Vice President at HTG Molecular Diagnostics, Inc. Prior to that, she worked as a Vice President-Translational Research at Genomic Health, Inc. from 2001 to 2010 and as a Senior VP-Research & Product Development at Foundation Medicine, Inc. from 2010 to 2012.
Dr. Cronin received her undergraduate and graduate degrees from the University of California, Davis and her doctorate from the University of California San Diego.
Eerdere bekende functies van Maureen T. Cronin
| Bedrijven | Functie | Einde |
|---|---|---|
| HTG MOLECULAR DIAGNOSTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 30-04-2020 |
| CELCUITY INC. | Directeur/Bestuurslid | 12-06-2019 |
| CELGENE | Corporate Officer/Principal | 01-01-2017 |
| FOUNDATION MEDICINE INC | Hoofd Techniek/Wetenschap/O&O | 01-01-2012 |
| GENOMIC HEALTH, INC. | Corporate Officer/Principal | 01-01-2010 |
Opleiding van Maureen T. Cronin
| University of California San Diego | Doctorate Degree |
| University of California, Davis | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CELCUITY INC. | Health Technology |
| HTG MOLECULAR DIAGNOSTICS, INC. | Commercial Services |
| Bedrijven in privébezit | 5 |
|---|---|
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |
ACLARA Biosciences, Inc.
 ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | Health Technology |
Genomic Health, Inc.
 Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |